An Epidemiological Network Model for Disease Outbreak Detection
暂无分享,去创建一个
[1] P E SARTWELL,et al. The distribution of incubation periods of infectious disease. , 1950, American journal of hygiene.
[2] R A Ross,et al. Phenotypic diversification in human neuroblastoma cells: expression of distinct neural crest lineages. , 1989, Cancer research.
[3] W. Alexander,et al. Novel zinc finger gene implicated as myc collaborator by retrovirally accelerated lymphomagenesis in Eμ-myc transgenic mice , 1991, Cell.
[4] Anton Berns,et al. Identification of cooperating oncogenes in Eμ-myc transgenic mice by provirus tagging , 1991, Cell.
[5] J. Squire,et al. NUB-7: a stable I-type human neuroblastoma cell line inducible along N- and S-type cell lineages. , 1994, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[6] R. Ross,et al. Human neuroblastoma I-type cells are malignant neural crest stem cells. , 1995, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[7] M. Schwab,et al. Conditional expression of N-myc in human neuroblastoma cells increases expression of alpha-prothymosin and ornithine decarboxylase and accelerates progression into S-phase early after mitogenic stimulation of quiescent cells. , 1996, Oncogene.
[8] P. Spierer,et al. Position-effect variegation in Drosophila depends on dose of the gene encoding the E2F transcriptional activator and cell cycle regulator. , 1996, Development.
[9] L. Hutwagner,et al. Using laboratory-based surveillance data for prevention: an algorithm for detecting Salmonella outbreaks. , 1997, Emerging infectious diseases.
[10] S. Wetterhall,et al. Medical care delivery at the 1996 Olympic Games. Centers for Disease Control and Prevention Olympics Surveillance Unit. , 1998, JAMA.
[11] M. Schwab,et al. MycN and IFNgamma cooperate in apoptosis of human neuroblastoma cells. , 1998, Oncogene.
[12] G. Sauvageau,et al. Stage-specific expression of polycomb group genes in human bone marrow cells. , 1998, Blood.
[13] U. Thorsteinsdóttir,et al. Functional antagonism of the Polycomb-Group genes eed and Bmi1 in hemopoietic cell proliferation. , 1999, Genes & development.
[14] R. Kingston,et al. Stabilization of Chromatin Structure by PRC1, a Polycomb Complex , 1999, Cell.
[15] A. Berns,et al. Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF. , 1999, Genes & development.
[16] M. Schwab,et al. MycN sensitizes neuroblastoma cells for drug-induced apoptosis , 1999, Oncogene.
[17] M. Vidal,et al. RYBP, a new repressor protein that interacts with components of the mammalian Polycomb complex, and with the transcription factor YY1 , 1999, The EMBO journal.
[18] R. DePinho,et al. The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus , 1999, Nature.
[19] A. Suzuki,et al. Xenopus embryonic E2F is required for the formation of ventral and posterior cell fates during early embryogenesis. , 2000, Molecular cell.
[20] Joseph B. Rayman,et al. Analysis of promoter binding by the E2F and pRB families in vivo: distinct E2F proteins mediate activation and repression. , 2000, Genes & development.
[21] Bruce Stillman,et al. Chromatin Association of Human Origin Recognition Complex, Cdc6, and Minichromosome Maintenance Proteins during the Cell Cycle: Assembly of Prereplication Complexes in Late Mitosis , 2000, Molecular and Cellular Biology.
[22] W. Ansorge,et al. Induction of cyclin E–cdk2 kinase activity, E2F‐dependent transcription and cell growth by Myc are genetically separable events , 2000, The EMBO journal.
[23] M. Eilers,et al. Expression of P27KIP1 is prognostic and independent of MYCN amplification in human neuroblastoma , 2001, International journal of cancer.
[24] E. Campo,et al. BMI-1 gene amplification and overexpression in hematological malignancies occur mainly in mantle cell lymphomas. , 2001, Cancer research.
[25] J. Trimarchi,et al. The E2F6 transcription factor is a component of the mammalian Bmi1-containing polycomb complex. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[26] R. Kingston,et al. Reconstitution of a functional core polycomb repressive complex. , 2001, Molecular cell.
[27] M. Lohuizen,et al. The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression , 2001, British Journal of Cancer.
[28] M. Vidal,et al. Mice doubly deficient for the Polycomb Group genes Mel18 and Bmi1 reveal synergy and requirement for maintenance but not initiation of Hox gene expression. , 2001, Development.
[29] R. Spang,et al. Role for E2F in Control of Both DNA Replication and Mitotic Functions as Revealed from DNA Microarray Analysis , 2001, Molecular and Cellular Biology.
[30] Michael Q. Zhang,et al. Use of Chromatin Immunoprecipitation To Clone Novel E2F Target Promoters , 2001, Molecular and Cellular Biology.
[31] F. Christians,et al. E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis. , 2001, Genes & development.
[32] M E Greenberg,et al. Myc requires distinct E2F activities to induce S phase and apoptosis. , 2001, Molecular cell.
[33] J. Bonventre,et al. TRIP‐Br: a novel family of PHD zinc finger‐ and bromodomain‐interacting proteins that regulate the transcriptional activity of E2F‐1/DP‐1 , 2001, The EMBO journal.
[34] S. Gonzalo,et al. Linking the Rb and polycomb pathways. , 2001, Molecular cell.
[35] Holger Christiansen,et al. Loss of a FYN-regulated differentiation and growth arrest pathway in advanced stage neuroblastoma. , 2002, Cancer cell.
[36] Nicola J. Rinaldi,et al. Transcriptional Regulatory Networks in Saccharomyces cerevisiae , 2002, Science.
[37] Brigitte M Pützer,et al. Gene expression changes in response to E2F1 activation. , 2002, Nucleic acids research.
[38] J. DeGregori,et al. The genetics of the E2F family of transcription factors: shared functions and unique roles. , 2002, Biochimica et biophysica acta.
[39] J. Nevins,et al. Interaction of YY1 with E2Fs, mediated by RYBP, provides a mechanism for specificity of E2F function , 2002, The EMBO journal.
[40] T. Volkert,et al. E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints. , 2002, Genes & development.
[41] Jeffrey M. Trimarchi,et al. Transcription: Sibling rivalry in the E2F family , 2002, Nature Reviews Molecular Cell Biology.
[42] J. Auwerx,et al. E2Fs regulate adipocyte differentiation. , 2002, Developmental cell.
[43] R. Kingston,et al. The Core of the Polycomb Repressive Complex Is Compositionally and Functionally Conserved in Flies and Humans , 2002, Molecular and Cellular Biology.
[44] J. D. Vos,et al. Comparison of gene expression profiling between malignant and normal plasma cells with oligonucleotide arrays , 2002, Oncogene.
[45] J. Knight. Harvard team suggests route to better bioterror alerts , 2003, Nature.
[46] J. Issa,et al. Enrichment for Histone H3 Lysine 9 Methylation at Alu Repeats in Human Cells* , 2003, Journal of Biological Chemistry.
[47] H. Cam,et al. Emerging roles for E2F: beyond the G1/S transition and DNA replication. , 2003, Cancer cell.
[48] G. Sauvageau,et al. Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells , 2003, Nature.
[49] G. Brodeur. Neuroblastoma: biological insights into a clinical enigma , 2003, Nature Reviews Cancer.
[50] Marcello Pagano,et al. Using temporal context to improve biosurveillance , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[51] R. Dalton. Fury at plan to split historic biology archive , 2003, Nature.
[52] Brad T. Sherman,et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.
[53] N. Dyson,et al. Cell cycle-dependent and cell cycle-independent control of transcription by the Drosophila E2F/RB pathway. , 2003, Genes & development.
[54] Irving L. Weissman,et al. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells , 2003, Nature.
[55] Kenneth D. Mandl,et al. Time series modeling for syndromic surveillance , 2003, BMC Medical Informatics Decis. Mak..
[56] Kristian Helin,et al. EZH2 is downstream of the pRB‐E2F pathway, essential for proliferation and amplified in cancer , 2003, The EMBO journal.
[57] Kevin S. Smith,et al. Bmi-1 regulation of INK4A-ARF is a downstream requirement for transformation of hematopoietic progenitors by E2a-Pbx1. , 2003, Molecular cell.
[58] S. Morrison,et al. Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation , 2003, Nature.
[59] N. Ferguson,et al. Planning for smallpox outbreaks , 2003, Nature.
[60] A. Otte,et al. Gene repression by Polycomb group protein complexes: a distinct complex for every occasion? , 2003, Current opinion in genetics & development.
[61] V. Orlando. Polycomb, Epigenomes, and Control of Cell Identity , 2003, Cell.
[62] Kenneth D. Mandl,et al. Integrating Syndromic Surveillance Data across Multiple Locations: Effects on Outbreak Detection Performance , 2003, AMIA.
[63] W. Lutz,et al. E2F Proteins Regulate MYCN Expression in Neuroblastomas* , 2003, The Journal of Biological Chemistry.
[64] R. Brookmeyer,et al. Public health vaccination policies for containing an anthrax outbreak , 2004, Nature.
[65] M. Schwab. MYCN in neuronal tumours. , 2004, Cancer letters.
[66] W. Gerald,et al. Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control , 2004, Nature.
[67] Urania G Dafni,et al. Algorithm for statistical detection of peaks--syndromic surveillance system for the Athens 2004 Olympic Games. , 2004, MMWR supplements.
[68] W. Lutz,et al. E2F and Sp1/Sp3 Synergize but Are Not Sufficient to Activate the MYCN Gene in Neuroblastomas* , 2004, Journal of Biological Chemistry.
[69] W. Dunsmuir,et al. Syndromic Surveillance for Influenzalike Illness in Ambulatory Care Setting , 2004, Emerging infectious diseases.
[70] D. Buckeridge,et al. Systematic Review: Surveillance Systems for Early Detection of Bioterrorism-Related Diseases , 2004, Annals of Internal Medicine.
[71] K. Helin,et al. E2F target genes: unraveling the biology. , 2004, Trends in biochemical sciences.
[72] A. Lund,et al. Polycomb complexes and silencing mechanisms. , 2004, Current opinion in cell biology.
[73] Aaron Aslanian,et al. Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics. , 2004, Genes & development.
[74] William B. Lober,et al. Review Paper: Implementing Syndromic Surveillance: A Practical Guide Informed by the Early Experience , 2003, J. Am. Medical Informatics Assoc..
[75] Chang-Nam Kim,et al. The Bmi-1 oncoprotein is overexpressed in human colorectal cancer and correlates with the reduced p16INK4a/p14ARF proteins. , 2004, Cancer letters.
[76] Kenneth D Mandl,et al. Measuring outbreak-detection performance by using controlled feature set simulations. , 2004, MMWR supplements.
[77] M. Lohuizen,et al. Stem Cells and Cancer The Polycomb Connection , 2004, Cell.
[78] S. Schrag,et al. SARS Surveillance during Emergency Public Health Response, United States, March–July 2003 , 2004, Emerging infectious diseases.
[79] T. Kajiume,et al. Polycomb group gene mel-18 modulates the self-renewal activity and cell cycle status of hematopoietic stem cells. , 2004, Experimental hematology.
[80] Al Ozonoff,et al. Bivariate method for spatio-temporal syndromic surveillance. , 2004, MMWR supplements.
[81] M. Lohuizen,et al. Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas , 2004, Nature.
[82] R. Young,et al. A common set of gene regulatory networks links metabolism and growth inhibition. , 2004, Molecular cell.
[83] Daniel B. Neill,et al. National Retail Data Monitor for public health surveillance. , 2004, MMWR supplements.
[84] M. Kulldorff,et al. Syndromic surveillance in public health practice, New York City. , 2004, Emerging infectious diseases.
[85] David M. Livingston,et al. E2F-Dependent Histone Acetylation and Recruitment of the Tip60 Acetyltransferase Complex to Chromatin in Late G1 , 2004, Molecular and Cellular Biology.
[86] J. Robins,et al. Transmissibility of 1918 pandemic influenza , 2004, Nature.
[87] M. Kulldorff,et al. A Space–Time Permutation Scan Statistic for Disease Outbreak Detection , 2005, PLoS medicine.
[88] Usa Prevention,et al. Rapid health response, assessment, and surveillance after a tsunami--Thailand, 2004-2005. , 2005, MMWR. Morbidity and mortality weekly report.
[89] A. Nizam,et al. Containing Pandemic Influenza at the Source , 2005, Science.
[90] J Coberly,et al. Public health monitoring tools for multiple data streams. , 2005, MMWR supplements.
[91] G. Glinsky,et al. Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. , 2005, The Journal of clinical investigation.
[92] T. Barrette,et al. Mining for regulatory programs in the cancer transcriptome , 2005, Nature Genetics.
[93] Andrew W. Moore,et al. Algorithms for rapid outbreak detection: a research synthesis , 2005, J. Biomed. Informatics.
[94] A Charlett,et al. Can syndromic surveillance data detect local outbreaks of communicable disease? A model using a historical cryptosporidiosis outbreak , 2005, Epidemiology and Infection.
[95] Colleen A Bradley,et al. BioSense: implementation of a National Early Event Detection and Situational Awareness System. , 2005, MMWR supplements.
[96] Xilin Yang,et al. SARS-related Perceptions in Hong Kong , 2005, Emerging infectious diseases.
[97] Anthony Scime,et al. Pocket Protein Complexes Are Recruited to Distinct Targets in Quiescent and Proliferating Cells , 2005, Molecular and Cellular Biology.
[98] D. Cummings,et al. Strategies for containing an emerging influenza pandemic in Southeast Asia , 2005, Nature.
[99] Ken P Kleinman,et al. Identifying pediatric age groups for influenza vaccination using a real-time regional surveillance system. , 2005, American journal of epidemiology.
[100] Pandemic influenza preparedness and mitigation in refugee and displaced populations: WHO guidelines for humanitarian agencies , 2006 .
[101] P. Horby,et al. Nonpharmaceutical Interventions for Pandemic Influenza, National and Community Measures , 2006, Emerging infectious diseases.